Professor Richard Adams
Projects as PI
1 of 11
- Access to AML data (01/08/2015 - 30/04/2018)
- Adults with acute myeloid leukaemia or high-risk myelodysplastic syndrome (16/09/2015 - 31/08/2025)
- Adults with acute myeloid leukaemia or high risk myelodysplastic syndrome - AML19
(30/07/2015 - 31/07/2022) - AML 17 Supply agreement (29/04/2009 - 15/11/2019)
- AML 18 - A trial for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome (01/06/2013 - 31/05/2025)
Projects as Co-Investigator
1 of 6
- Adjuvant radiotherapy in patients with high-risk primary cutaneous
Squamous Cell Carcinoma AFTER surgery (SCC-AFTER): an open label, multicentre, two-arm phase III randomised trial (01/01/2023 - 31/12/2030) - AML pick a winner programme (Ll-1 Trial) (10/01/2014 - 30/06/2021)
- A phase 2 study of the monocyte-targeted histone deacetylase inhibitor tefinostat in chronic myelomonocytic leukaemia (01/07/2015 - 30/11/2019)
- A programme of development for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome (01/02/2013 - 31/01/2020)
- Arthritis Research UK Treatment Centre (01/08/2012 - 30/09/2020)
